Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Desmet [Member] Accounts Payable [Member] Vendor One [Member] Vendor Two [Member] Vendor Three [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Derivative Instrument [Axis] Convertible Note Conversion Options [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Antidilutive Securities [Axis] Warrant [Member] Convertible Note [Member] Title and Position [Axis] Chief Executive Officer [Member] Short-Term Debt, Type [Axis] One Year Convertible Note Xyra Corp [Member] Long-Term Debt, Type [Axis] Xyra Corp Convertible Notes [Member] EIDL [Member] Measurement Input Type [Axis] Measurement Input, Share Price [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Term [Member] Measurement Input Number Of Shares Issuable [Member] Counterparty Name [Axis] Two Accredited Investors [Member] Class of Stock [Axis] Units [Member] Various Consultants [Member] Certain Warrant Holders [Member] Warrants [Member] Stock Conversion Description [Axis] Cashless Exercise Of Warrants [Member] Award Type [Axis] Exercise Price Range [Axis] Exercise price $ 0.013 [Member] Exercise price $ 0.017 [Member] Exercise price $ 0.030 [Member] Exercise price $ 0.060 [Member] Exercise price $ 0.090 [Member] Consolidation Items [Axis] Operating Segments [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Accounts receivable Prepaid expenses Total current assets Other assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Current liabilities: Accounts payable and accrued expenses Promissory notes payable – Related party Convertible notes payable, net of discount Derivative liability Total current liabilities Note payable, non-current Total liabilities Commitments and contingencies (Note 8) Stockholders' equity (deficit): Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and June 30, 2025 Common stock, $0.001 par value, 1,000,000,000 shares authorized, 309,720,740 and 289,156,340 shares issued and outstanding as of March 31, 2026 and June 30, 2025, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity (deficit) Total liabilities and stockholders' equity (deficit) Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of revenue Gross profit General and administrative expenses Research and development expenses Total operating expenses Loss from operations Other Income (expense) Gain on patent assignment Interest expense Discount amortization Change in fair value of derivative liability Net income (loss) Net income (loss) per share, Basic Net income (loss) per share, Diluted Weighted average shares outstanding, Basic Weighted average shares outstanding, Diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Fair value of warrants granted for services Fair value of common stock issued to settle accrued payroll and payroll taxes – related parties Fair value of common stock issued to settle accrued payroll and payroll taxes - related parties, shares Fair value of warrants issued to settle accrued payroll and payroll taxes – related parties Extinguishment of accrued payroll and payroll taxes – related parties treated as contribution of capital Proceeds from sale of common stock units Proceeds from units issued to shareholders, shares Fair value of common stock issued for services Fair value of common stock issued for services, shares Cashless exercise of warrants Cashless exercise of warrants, shares Net income Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Operating activities: Net income (loss) Adjustments to reconcile net income (loss) to net cash used in operating activities: Debt discount amortization Change in fair value of derivative liability Fair value of common stock issued for services Fair value of warrants granted for services Gain on patent assignment Effect of changes in: Accounts receivable Prepaid expenses Operating lease right of use asset Accounts payable and accrued expenses Accrued payroll and payroll taxes – related parties Operating lease liability Net cash used in operating activities Investing activities: Proceeds from patent assignment Net cash provided by investing activities Financing activities: Proceeds from convertible note payable Proceeds from common stock units Proceeds from note payable Repayment of note payable Net cash provided by (used in) financing activities Net (decrease) increase in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental disclosures of cash flow information: Cash paid for interest Cash paid for income taxes Supplemental disclosures of non-cash transactions: Conversion feature of convertible notes payable accounted as derivative liability Fair value of common stock and warrants granted to settle accrued payroll and payroll taxes - related parties Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Summary of Significant Accounting Policies Promissory Notes Payable Related Party Promissory Notes payable – Related party Convertible Notes Payable Convertible Notes Payable Debt Disclosure [Abstract] Note Payable Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Liability Equity [Abstract] Stockholders’ Deficit Segment Reporting [Abstract] Segment Information Subsequent Events [Abstract] Subsequent Events Basis of Presentation Going Concern Use of Estimates Revenue Recognition Derivative Financial Instruments Fair Value Measurement Advertising Costs Research and Development Costs Net Income (Loss) Per Share Concentrations Segments Recent Accounting Pronouncements Schedule of derivative by level Schedule of anti-dilutive shares Schedule of note payable- related party Schedule of convertible notes Schedule of notes payable Schedule of rollforward of derivative liability Schedule of assumptions used Schedule of warrant activity Schedule of warrants outstanding and exercisable Schedule of segment information Defined Benefit Plan [Table] Derivative [Line Items] Derivative liability, fair value Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive shares Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Loss from operations Net cash used in operating activities Accumulated deficit Cash in amount Revenues Advertising expenses Research and development costs Concentration risk, percentage Note Payable - Related Party 8% promissory note payable Accrued interest Net DisclosureTable [Table] DisclosureLineItemElements [Line Items] Note payable Interest rate Short-Term Debt [Table] Short-Term Debt [Line Items] 8% convertible note payable Accrued interest Debt discount Net Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Convertible notes payable Debt maturity date, start range Debt maturity date, end range Debt stated interest rate Derivative Liability Notes payable Proceeds from loans Debt instrument interest rate Note payable At issuance, December 5, 2025, January 15, 2026 and January 30, 2026 Change in fair value of derivative liability Business Combination [Table] Derivatives, Fair Value [Line Items] Assumption used Derivative Liability, Subject to Master Netting Arrangement, before Offset Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Warrants outstanding, beginning balance Weighted average exercise price, beginning balance Weighted average remaining contractual life Warrants granted Weighted average exercise price, granted Weighted average remaining contractual life, granted Warrants exercised Weighted average exercise price, exercised Weighted average remaining contractual life, exercised Warrants expired/retired Weighted average exercise price, expired/retired Weighted average remaining contractual life, expired/retired Warrants outstanding, ending balance Weighted average exercise price, ending balance Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Warrants outstanding Weighted average remaining life, warrants outstanding Weighted average exercise price Warrants exercisable Weighted average remaining life, warrants exercisable Stock, Class of Stock [Table] Class of Stock [Line Items] Stock issued new, shares Unit description Proceeds from sale of equity Warrants retired, shares Stock issued for compensation, shares Stock issued for compensation, value Stock converted, shares converted Stock converted, shares issued Intrinsic value of warrants Segment Reporting [Table] Segment Reporting [Line Items] Gross profit Salaries Share based compensation Consulting fees Professional fees Rent expense Travel expense Other operating expenses Total operating expenses Net operating loss Interest expense Discount amortization Number of reportable segments Number of operating segments Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Cost of Revenue Interest Expense, Nonoperating Shares, Outstanding Issuance of Stock and Warrants for Services or Claims Fair Value Adjustment of Warrants Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Accounts Payable and Accrued Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Repayments of Notes Payable Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name ConvertibleNotesTextBlock Long-Term Debt, Gross Debt Instrument, Unamortized Discount Derivative Liability [Default Label] Increase (Decrease) in Derivative Liabilities Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Nonoperating Income (Expense)